oru.sePublications
Change search
Link to record
Permanent link

Direct link
BETA
Hagberg, Lars
Alternative names
Publications (10 of 30) Show all publications
Hagberg, L., Winkvist, A., Brekke, H. K., Bertz, F., Johansson, E. H. & Huseinovic, E. (2019). Cost-effectiveness and quality of life of a diet intervention postpartum: 2-year results from a randomized controlled trial. BMC Public Health, 19, Article ID 38.
Open this publication in new window or tab >>Cost-effectiveness and quality of life of a diet intervention postpartum: 2-year results from a randomized controlled trial
Show others...
2019 (English)In: BMC Public Health, ISSN 1471-2458, E-ISSN 1471-2458, Vol. 19, article id 38Article in journal (Refereed) Published
Abstract [en]

Background: Pregnancy has been identified as a contributor to obesity. We have shown that a diet intervention postpartum produced a 2-y weight loss of 8%. Here, we present the impact of the diet intervention on cost-effectiveness and explore changes in quality of life (QOL).

Methods: A total of 110 postpartum women with overweight/obesity were randomly assigned to diet (D-group) or control (C-group). D-group received a 12-wk diet intervention within primary health care followed by monthly emails up to the 1-y follow-up. C-group received a brochure. Changes in QOL were measured using the 36-item Short Form Health Survey and EQ-5D. The analysis of cost-effectiveness was a cost-utility analysis with a health care perspective and included costs of intervention for stakeholder, quality-adjusted life-years (QALYs) gained and savings in health care. The likelihood of cost-effectiveness was examined using the net monetary benefit method.

Results: The D-group increased their QOL more than the C-group at 12 wk. and 1 y, with pronounced differences for the dimensions general health and mental health, and the mental component summary score (all p<0.05). Cost per gained QALY was 1704-7889 USD. The likelihood for cost-effectiveness, based on a willingness to pay 50,000 USD per QALY, was 0.77-1.00.

Conclusions: A diet intervention that produced clinically relevant postpartum weight loss also resulted in increased QOL and was cost-effective.

Trial registration: Clinical trials, NCT01949558, 2013-09-24

Place, publisher, year, edition, pages
BMC, 2019
Keywords
Cost-effectiveness, Quality of life, Weight loss, Postpartum, Primary health care
National Category
Public Health, Global Health, Social Medicine and Epidemiology
Identifiers
urn:nbn:se:oru:diva-71676 (URN)10.1186/s12889-018-6356-y (DOI)000455222600008 ()30621673 (PubMedID)2-s2.0-85059795342 (Scopus ID)
Funder
Forte, Swedish Research Council for Health, Working Life and Welfare, 2011-0193
Note

Funding Agencies:

Swedish government under the ALF agreement  

Längmanska kulturfonden 

Available from: 2019-01-23 Created: 2019-01-23 Last updated: 2019-01-23Bibliographically approved
Ssegonja, R., Alaie, I., Philipsson, A., Hagberg, L., Sampaio, F., Möller, M., . . . Feldman, I. (2019). Depressive disorders in adolescence, recurrence in early adulthood, and healthcare usage in mid-adulthood: A longitudinal cost-of-illness study. Journal of Affective Disorders, 258, 33-41
Open this publication in new window or tab >>Depressive disorders in adolescence, recurrence in early adulthood, and healthcare usage in mid-adulthood: A longitudinal cost-of-illness study
Show others...
2019 (English)In: Journal of Affective Disorders, ISSN 0165-0327, E-ISSN 1573-2517, Vol. 258, p. 33-41Article in journal (Refereed) Epub ahead of print
Abstract [en]

BACKGROUND: Depression in adolescence is associated with increased healthcare consumption in adulthood, but prior research has not recognized the heterogeneity of depressive disorders. This paper investigated the additional healthcare usage and related costs in mid-adulthood for individuals with adolescent depression, and examined the mediating role of subsequent depression in early adulthood.

METHODS: This study was based on the Uppsala Longitudinal Adolescent Depression Study, initiated in Sweden in the early 1990s. Depressive disorders were assessed in adolescence (age 16-17) and early adulthood (age 19-30). Healthcare usage and related costs in mid-adulthood (age 31-40) were estimated using nationwide population-based registries. Participants with specific subtypes of adolescent depression (n = 306) were compared with matched non-depressed peers (n = 213).

RESULTS: Women with persistent depressive disorder (PDD) in adolescence utilized significantly more healthcare resources in mid-adulthood. The association was not limited to psychiatric care, and remained after adjustment for individual and parental characteristics. The total additional annual cost for a single age group of females with a history of PDD at a population level was estimated at 3.10 million USD. Depression recurrence in early adulthood mediated the added costs for psychiatric care, but not for somatic care.

LIMITATIONS: Primary health care data were not available, presumably resulting in an underestimation of the true healthcare consumption. Estimates for males had limited precision due to a relatively small male proportion.

CONCLUSIONS: On a population level, the additional healthcare costs incurred in mid-adulthood in females with a history of adolescent PDD are considerable. Early treatment and prevention should be prioritized.

Place, publisher, year, edition, pages
Elsevier, 2019
Keywords
Adolescence, Adulthood, Depression, Direct costs, Non-psychiatric healthcare, Psychiatric healthcare
National Category
Psychiatry
Identifiers
urn:nbn:se:oru:diva-75560 (URN)10.1016/j.jad.2019.07.077 (DOI)31382102 (PubMedID)
Available from: 2019-08-09 Created: 2019-08-09 Last updated: 2019-08-09Bibliographically approved
Alaie, I., Philipsson, A., Ssegonja, R., Hagberg, L., Feldman, I., Sampaio, F., . . . Jonsson, U. (2019). Uppsala Longitudinal Adolescent Depression Study (ULADS). BMJ Open, 9(3), Article ID e024939.
Open this publication in new window or tab >>Uppsala Longitudinal Adolescent Depression Study (ULADS)
Show others...
2019 (English)In: BMJ Open, ISSN 2044-6055, E-ISSN 2044-6055, Vol. 9, no 3, article id e024939Article in journal (Refereed) Published
Abstract [en]

Purpose: To present the Uppsala Longitudinal Adolescent Depression Study, initiated in Uppsala, Sweden, in the early 1990s. The initial aim of this epidemiological investigation was to study the prevalence, characteristics and correlates of adolescent depression, and has subsequently expanded to include a broad range of social, economic and health-related long-term outcomes and cost-of-illness analyses.

Participants: The source population was first-year students (aged 16-17) in upper-secondary schools in Uppsala during 1991-1992, of which 2300 (93%) were screened for depression. Adolescents with positive screening and sex/age-matched peers were invited to a comprehensive assessment. A total of 631 adolescents (78% females) completed this assessment, and 409 subsequently completed a 15year follow-up assessment. At both occasions, extensive information was collected on mental disorders, personality and psychosocial situation. Detailed social, economic and health-related data from 1993 onwards have recently been obtained from the Swedish national registries for 576 of the original participants and an age-matched reference population (N=200 000).

Findings to date: The adolescent lifetime prevalence of a major depressive episode was estimated to be 11.4%. Recurrence in young adulthood was reported by the majority, with a particularly poor prognosis for those with a persistent depressive disorder or multiple somatic symptoms. Adolescent depression was also associated with an increased risk of other adversities in adulthood, including additional mental health conditions, low educational attainment and problems related to intimate relationships.

Future plans: Longitudinal studies of adolescent depression are rare and must be responsibly managed and utilised. We therefore intend to follow the cohort continuously by means of registries. Currently, the participants are approaching mid-adulthood. At this stage, we are focusing on the overall long-term burden of adolescent depression. For this purpose, the research group has incorporated expertise in health economics. We would also welcome extended collaboration with researchers managing similar datasets.

Place, publisher, year, edition, pages
BMJ Publishing Group Ltd, 2019
National Category
General Practice Psychiatry
Identifiers
urn:nbn:se:oru:diva-75243 (URN)10.1136/bmjopen-2018-024939 (DOI)000471144900167 ()30826765 (PubMedID)2-s2.0-85062413050 (Scopus ID)
Funder
Swedish Research Council, 2014-10092Forte, Swedish Research Council for Health, Working Life and Welfare
Note

Funding Agencies:

Uppsala-Orebro Regional Research Council  RFR-738411  RFR-652841 

Uppsala County Council's Funds for Clinical Research  LUL-713161 

Medical Training and Research Agreement Funds (ALF) from Uppsala University Hospital 

Märta and Nicke Nasvell Foundation  

Clas Groschinsky Memorial Fund  

Söderström-Königska Foundation  

Foundation in Memory of Professor Bror Gadelius 

Available from: 2019-07-25 Created: 2019-07-25 Last updated: 2019-07-25Bibliographically approved
Lundqvist, S., Börjesson, M., Larsson, M. E. H., Cider, Å. & Hagberg, L. (2019). Which patients benefit from physical activity on prescription (PAP)?: A prospective observational analysis of factors that predict increased physical activity. BMC Public Health, 19(1), Article ID 482.
Open this publication in new window or tab >>Which patients benefit from physical activity on prescription (PAP)?: A prospective observational analysis of factors that predict increased physical activity
Show others...
2019 (English)In: BMC Public Health, ISSN 1471-2458, E-ISSN 1471-2458, Vol. 19, no 1, article id 482Article in journal (Refereed) Published
Abstract [en]

BACKGROUND: There is robust evidence that regular physical activity (PA) has positive health effects. However, the best PA methods and the most important correlates for promoting PA remain unclear. Physical activity on prescription (PAP) aims to increase the patient's motivation for and level of PA. This study investigated possible predictive baseline correlates associated with changes in the PA level over a 6-month period of PAP treatment in order to identify the primary care patients most likely to benefit from a PAP intervention.

METHODS: The study included 444 patients with metabolic risk factors who were aged 27 to 85 years and physically inactive. The patients received PAP treatment that included individual counseling plus an individually-tailored PA recommendation with a written prescription and individualised structured follow-up for 6 months. Eight baseline correlates of PA were analysed against the PA level at the 6-month follow-up in a predictor analysis.

RESULTS: Five baseline correlates predicted the PA level at the 6-month follow-up: self-efficacy expectations for changing PA; the patient's preparedness and confidence regarding readiness to change PA; a BMI <  30; and a positive valued physical health. The proportion of patients increasing the PA level and achieving a PA level that was in accordance with public health recommendations was higher with a positive valued baseline correlate. The odds of achieving the recommended PA level increased substantially when 2 to 4 predictive correlates were present. PA levels increased to a greater extent among patients with low PA at baseline than patients with high PA at baseline, especially in combination with 2 to 4 positively-valued correlates (87-95% vs. 62-75%).

CONCLUSIONS: This study identified potential predictive correlates of an increased PA level after a 6-month PAP intervention. This contributes to our understanding of PAP and could help individualise PAP support. The proportion of patients with the lowest PA level at baseline increased their PA level in a higher extent (84%) and thus may benefit the most from PAP. These results have clinical implications for behavioural change in those patients having the greatest health gains by increasing their PA level.

TRIAL REGISTRATION: ClinicalTrials.gov ; NCT03586011 . Retrospectively registered on July 17, 2018.

Place, publisher, year, edition, pages
BioMed Central, 2019
Keywords
Correlates of physical activity, Health behaviour, Metabolic syndrome, Physical activity, Physical activity on prescription, Predictive factor
National Category
General Practice
Identifiers
urn:nbn:se:oru:diva-74198 (URN)10.1186/s12889-019-6830-1 (DOI)000467019900013 ()31046720 (PubMedID)2-s2.0-85065190313 (Scopus ID)
Note

Funding Agency:

Närhälsan Research & Development Primary Health Care, Region Västra Götaland, Sweden

Available from: 2019-05-14 Created: 2019-05-14 Last updated: 2019-06-19Bibliographically approved
Jansson, M., Cao, Y., Nilsson, K., Larsson, P.-G. & Hagberg, L. (2018). Cost-effectiveness of antibiotic prophylaxis in elective cesarean section. Cost Effectiveness and Resource Allocation, 16, Article ID 66.
Open this publication in new window or tab >>Cost-effectiveness of antibiotic prophylaxis in elective cesarean section
Show others...
2018 (English)In: Cost Effectiveness and Resource Allocation, ISSN 1478-7547, E-ISSN 1478-7547, Vol. 16, article id 66Article in journal (Refereed) Published
Abstract [en]

Background: The proportion of pregnant women delivered by cesarean section has increased steadily during the past three decades. The risk of infection is 10-fold augmented after elective cesarean section compared to vaginal delivery. Antibiotic prophylaxis may reduce endometritis by 62% and superficial wound infection by 38% after elective cesarean section. International guidelines recommend antibiotic prophylaxis in elective cesarean section, but this procedure is not routinely followed in Sweden. Studies of costs of antibiotic prophylaxis in cesarean section show conflicting results and are based on substantially different incidence of postoperative infections. No study of costs of antibiotic prophylaxis in elective cesarean section in a Swedish or Nordic context has been pursued. The aim of this study was to investigate if antibiotic prophylaxis is cost-reducing in elective cesarean section in orebro County, Sweden.

Methods: All women undergoing elective cesarean in the Region orebro County health care system during 2011-2012 were eligible for inclusion. Postoperative infections and risk factors for infections were registered. A hypothetical situation in which all participants had received antibiotic prophylaxis was compared to the actual situation, in which none of them had received antibiotic prophylaxis. The reduction in the risk of postoperative infections resulting from antibiotic prophylaxis was based on a meta-analysis. Costs for in-patient care of postoperative infections were extracted from the accounting system, and costs for out-patient care were calculated according to standard costs. Costs for antibiotic prophylaxis were calculated and compared with the cost reduction that would be implied by the introduction of such prophylaxis.

Results: The incidences of deep and superficial surgical site infection were 3.5% and 1.3% respectively. Introduction of antibiotic prophylaxis would reduce health care costs by 31 Euro per cesarean section performed (95% credible interval 4-58 Euro). The probability of cost-saving was 99%.

Conclusions: Antibiotic prophylaxis in elective cesarean section is cost-reducing in this health care setting. Our results indicate that the introduction of antibiotic prophylaxis in elective cesarean section can also be cost-saving in low infection rate settings.

Trial registration Ethical approval was given by the Regional Ethical Review Board in Uppsala (registration number 2013/484).

Place, publisher, year, edition, pages
BMC, 2018
Keywords
Cesarean section, Surgical wound infection, Antibiotic prophylaxis, Costs and cost analysis
National Category
Health Care Service and Management, Health Policy and Services and Health Economy
Identifiers
urn:nbn:se:oru:diva-71239 (URN)10.1186/s12962-018-0168-x (DOI)000453740600001 ()30574024 (PubMedID)2-s2.0-85058818087 (Scopus ID)
Available from: 2019-01-09 Created: 2019-01-09 Last updated: 2019-01-09Bibliographically approved
Dahlberg, K., Philipsson, A., Hagberg, L., Jaensson, M., Hälleberg Nyman, M. & Nilsson, U. (2017). Cost-effectiveness of a systematic e-assessed follow up of postoperative recovery after day surgery: a multicentre randomized controlled trial. In: : . Paper presented at 4th International Conference for PeriAnaesthesia Nurses, Sydney, Australia, November 1-4, 2017.
Open this publication in new window or tab >>Cost-effectiveness of a systematic e-assessed follow up of postoperative recovery after day surgery: a multicentre randomized controlled trial
Show others...
2017 (English)Conference paper, Oral presentation with published abstract (Refereed)
National Category
Nursing
Identifiers
urn:nbn:se:oru:diva-57059 (URN)
Conference
4th International Conference for PeriAnaesthesia Nurses, Sydney, Australia, November 1-4, 2017
Available from: 2017-04-18 Created: 2017-04-18 Last updated: 2019-04-05Bibliographically approved
Dahlberg, K., Philipsson, A., Hagberg, L., Jaensson, M., Hälleberg Nyman, M. & Nilsson, U. (2017). Cost-effectiveness of a systematic e-assessed follow-up of postoperative recovery after day surgery: a multicentre randomized trial. British Journal of Anaesthesia, 119(5), 1039-1046
Open this publication in new window or tab >>Cost-effectiveness of a systematic e-assessed follow-up of postoperative recovery after day surgery: a multicentre randomized trial
Show others...
2017 (English)In: British Journal of Anaesthesia, ISSN 0007-0912, E-ISSN 1471-6771, Vol. 119, no 5, p. 1039-1046Article in journal (Refereed) Published
Abstract [en]

Background: Most surgeries are done on a day-stay basis. Recovery assessment by phone points (RAPP) is a smartphonebased application (app) to evaluate patients after day surgery. The aim of this study was to estimate the cost-effectiveness of using RAPP for follow-up on postoperative recovery compared with standard care.

Methods: This study was a prospective parallel single-blind multicentre randomized controlled trial. Participants were randomly allocated to the intervention group using RAPP or the control group receiving standard care. A cost-effectiveness analysis was performed based on individual data and included costs for the intervention, health effect [quality-adjusted life-years (QALYs)], and costs or savings in health-care use.

Results: The mean cost for health-care consumption during 2 weeks after surgery was estimated at e37.29 for the intervention group and e60.96 for the control group. The mean difference was e23.66 (99% confidence interval 46.57 to0.76; P¼0.008). When including the costs of the intervention, the cost-effectiveness analysis showed net savings of e4.77 per patient in favour of the intervention. No difference in QALYs gained was seen between the groups (P¼0.75). The probability of the intervention being cost-effective was 71%.

Conclusions: This study shows that RAPP can be cost-effective but had no effect on QALY. RAPP can be a cost-effective toolin providing low-cost health-care contacts and in systematically assessing the quality of postoperative recovery.

Clinical trial registration:NCT02492191

Place, publisher, year, edition, pages
Oxford University Press, 2017
Keywords
Ambulatory surgery, cost effectiveness, mobile applications, postoperative period
National Category
Anesthesiology and Intensive Care
Identifiers
urn:nbn:se:oru:diva-61954 (URN)10.1093/bja/aex332 (DOI)000413642900027 ()29077819 (PubMedID)2-s2.0-85034731856 (Scopus ID)
Funder
Forte, Swedish Research Council for Health, Working Life and Welfare, 2013-4765Swedish Research Council, 2015-02273
Available from: 2017-10-25 Created: 2017-10-25 Last updated: 2019-03-26Bibliographically approved
Hagberg, L., Hermansson, L. M., Fredriksson, C. & Pettersson, I. (2017). Cost-effectiveness of powered mobility devices for elderly people with disability. Disability and Rehabilitation: Assistive Technology, 12(2), 115-120
Open this publication in new window or tab >>Cost-effectiveness of powered mobility devices for elderly people with disability
2017 (English)In: Disability and Rehabilitation: Assistive Technology, ISSN 1748-3107, E-ISSN 1748-3115, Vol. 12, no 2, p. 115-120Article in journal (Refereed) Published
Abstract [en]

Purpose: The aim of this study was to analyse the cost-effectiveness of prescribing powered mobility devices (PMDs) to elderly users.

Methods: Forty-five persons participated in the preand post-intervention study with a follow-up at four months. All participants were prescribed a scooter model and were offered individual support to get started using the PMD. In the analysis, the use of the PMD was compared to the situation prior to its use. The cost-utility analysis takes a societal perspective and considers costs, savings and quality of life (QoL) using answers to the EQ-5D questionnaire.

Results: Costs for the first year with the PMD were 1395 USD and then 592 USD per subsequent year. There was a significant decrease in transportation costs and in relatives' time use, but the increase in QoL of 0.041 was not significant. Costs per gained quality adjusted life year (QALY) were 12 400-14 700 USD/QALY if the value of time saved not was considered and 600-2900 USD/QALY when an hour was valued at 3.6 USD.

Conclusion: Prescription of PMDs to elderly users might be cost-effective. However, there are shortcomings in measuring QALY gains from the use of a PMD, and it is unclear how time savings among relatives should be valued.

Implications for Rehabilitation

  • Prescription of powered mobility devices for the elderly with disability seems to be cost effective and should be a standard intervention.

  • In economic evaluations of powered mobility devices and other assistive devices, the commonly used analyses methods are not always appropriate and therefore need to be adjusted.

Place, publisher, year, edition, pages
Taylor & Francis, 2017
Keywords
Assistive devices; cost-utility analysis; QALY
National Category
Occupational Therapy
Research subject
Nursing Science w. Occupational Therapy Focus
Identifiers
urn:nbn:se:oru:diva-40113 (URN)10.3109/17483107.2014.1002540 (DOI)000396533100002 ()25634493 (PubMedID)2-s2.0-84938500069 (Scopus ID)
Note

Funding Agencies:

Swedish Institute of Assistive Technology

Promobilia Foundation, Sweden

Available from: 2015-01-02 Created: 2015-01-02 Last updated: 2017-12-05Bibliographically approved
Wilhelmsson, A., Roos, M., Hagberg, L., Wengström, Y. & Blomberg, K. (2017). Motivation to uphold physical activity in women with breast cancer during adjuvant chemotherapy treatment. European Journal of Oncology Nursing, 29, 17-22, Article ID S1462-3889(17)30039-X.
Open this publication in new window or tab >>Motivation to uphold physical activity in women with breast cancer during adjuvant chemotherapy treatment
Show others...
2017 (English)In: European Journal of Oncology Nursing, ISSN 1462-3889, E-ISSN 1532-2122, Vol. 29, p. 17-22, article id S1462-3889(17)30039-XArticle in journal (Refereed) Published
Abstract [en]

PURPOSE: Physical activity (PA) is important for recovery after a breast cancer diagnosis; however, women's motivation to engage in PA can be impacted by disease and/or treatment, and can therefore be a challenge. This study explored factors associated with PA levels during chemotherapy among women with breast cancer.

METHOD: The study had a cross-sectional descriptive and comparative design using a study-specific questionnaire. One hundred women with breast cancer receiving adjuvant chemotherapy were included. Data were analysed by Pearson's correlation coefficient and linear regression. The open question was subjected to manifest content analysis.

RESULTS: Identified factors associated with engaging in PA during chemotherapy treatment were: being physically active before diagnosis, and the information given by the oncology nurse before the treatment start. The physically active women experienced higher psychological wellbeing, less fatigue, and faster recovery after treatment. They also experienced an overall feeling of fitness.

CONCLUSION: It seems that PA is associated with less fatigue, better recovery between chemotherapy treatments, and a better mental condition leading to wellbeing. Information given by the oncology nurse may be an important factor for being physically active. Women with breast cancer need to get specific advice about and support in engaging in PA to feel better during chemotherapy treatment. Further research is required to develop guidelines for advice about and support regarding PA during chemotherapy treatment.

Place, publisher, year, edition, pages
Elsevier, 2017
Keywords
Breast cancer, Chemotherapy, Physical activity, Symptoms
National Category
Nursing Cancer and Oncology
Research subject
Caring sciences
Identifiers
urn:nbn:se:oru:diva-59082 (URN)10.1016/j.ejon.2017.03.008 (DOI)000407405700004 ()28720261 (PubMedID)2-s2.0-85018950656 (Scopus ID)
Available from: 2017-08-12 Created: 2017-08-12 Last updated: 2018-09-13Bibliographically approved
Lundqvist, S., Börjesson, M., Larsson, M. E. H., Hagberg, L. & Cider, Å. (2017). Physical Activity on Prescription (PAP), in patients with metabolic risk factors: A 6-month follow-up study in primary health care. PLoS ONE, 12(4), Article ID e0175190.
Open this publication in new window or tab >>Physical Activity on Prescription (PAP), in patients with metabolic risk factors: A 6-month follow-up study in primary health care
Show others...
2017 (English)In: PLoS ONE, ISSN 1932-6203, E-ISSN 1932-6203, Vol. 12, no 4, article id e0175190Article in journal (Refereed) Published
Abstract [en]

There is strong evidence that inadequate physical activity (PA) leads to an increased risk of lifestyle-related diseases and premature mortality. Physical activity on prescription (PAP) is a method to increase the level of PA of patients in primary care, but needs further evaluation. The aim of this observational study was to explore the association between PAP-treatment and the PA level of patients with metabolic risk factors and the relationship between changes in the PA level and health outcomes at the 6 month follow-up. This study included 444 patients in primary care, aged 27-85 years (56% females), who were physically inactive with at least one component of metabolic syndrome. The PAP-treatment model included: individualized dialogue concerning PA, prescribed PA, and a structured follow-up. A total of 368 patients (83%) completed the 6 months of follow-up. Of these patients, 73% increased their PA level and 42% moved from an inadequate PA level to sufficient, according to public health recommendations. There were significant improvements (p <= 0.05) in the following metabolic risk factors: body mass index, waist circumference, systolic blood pressure, fasting plasma glucose, cholesterol, and low density lipoprotein. There were also significant improvements regarding health-related quality of life, assessed by the Short Form 36, in: general health, vitality, social function, mental health, role limitation-physical/emotional, mental component summary, and physical component summary. Regression analysis showed a significant association between changes in the PA level and health outcomes. During the first 6-month period, the caregiver provided PAP support 1-2 times. This study indicates that an individual-based model of PAP-treatment has the potential to change people's PA behavior with improved metabolic risk factors and self-reported quality of life at the 6 month follow-up. Thus, PAP seems to be feasible in a clinical primary care practice, with minimum effort from healthcare professionals.

Place, publisher, year, edition, pages
Public Library of Science, 2017
National Category
Gerontology, specialising in Medical and Health Sciences
Identifiers
urn:nbn:se:oru:diva-57776 (URN)10.1371/journal.pone.0175190 (DOI)000399955200040 ()28403151 (PubMedID)2-s2.0-85017651246 (Scopus ID)
Note

Funding Agency:

Närhälsan Research & Development Primary Health Care, Region Västra Götaland

Available from: 2017-05-23 Created: 2017-05-23 Last updated: 2018-09-04Bibliographically approved
Organisations

Search in DiVA

Show all publications